Immunity markers | Event/N (%) | Model 1 | Â | Model 2 | Â |
---|---|---|---|---|---|
 |  | OR (95% CI) | P-value | OR (95% CI) | P-value |
NLR | 142/956 (14.85%) | Â | Â | Â | Â |
 Q1 (≤ 1.26) | 24/232 (10.34%) | Ref | Ref | Ref | Ref |
 Q2 (> 1.26, ≤1.71) | 35/257 (13.62%) | 1.36 (0.79, 2.39) | 0.275 | 1.20 (0.63, 2.33) | 0.580 |
 Q3 (> 1.71, ≤2.35) | 39/241 (16.18%) | 1.67 (0.98, 2.92) | 0.064 | 1.80 (0.95, 3.45) | 0.073 |
 Q4 (> 2.35) | 44/226 (19.47%) | 2.10 (1.24, 3.63) | 0.007 | 2.88 (1.54, 5.55) | 0.001 |
PLR | 142/956 (14.85%) | Â | Â | Â | Â |
 Q1 (≤ 71.07) | 27/231 (11.69%) | Ref | Ref | Ref | Ref |
 Q2 (> 71.07, ≤93.79) | 38/267 (14.23%) | 1.25 (0.74, 2.14) | 0.401 | 1.17 (0.62, 2.22) | 0.637 |
 Q3 (> 93.79, ≤126.81) | 36/236 (15.25%) | 1.35 (0.79, 2.33) | 0.268 | 1.23 (0.66, 2.33) | 0.514 |
 Q4 (> 126.81) | 41/222 (18.47%) | 1.71 (1.02, 2.92) | 0.045 | 1.56 (0.84, 2.95) | 0.167 |
SII | 142/956 (14.85%) | Â | Â | Â | Â |
 Q1 (≤ 213.61) | 26/231 (11.26%) | Ref | Ref | Ref | Ref |
 Q2 (> 213.61, ≤309.45) | 33/258 (12.79%) | 1.15 (0.67, 2.00) | 0.614 | 1.32 (0.67, 2.65) | 0.420 |
 Q3 (> 309.45, ≤445.76) | 39/247 (15.79%) | 1.44 (0.85, 2.48) | 0.181 | 1.73 (0.90, 3.40) | 0.104 |
 Q4 (> 445.76) | 44/220 (20.00%) | 1.97 (1.17, 3.37) | 0.011 | 2.59 (1.39, 5.00) | 0.003 |